ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/2,7,9,12,17-Pentaazaoctadecanedioic acid, 4,15-dihydroxy-10-(1-methylethyl)-8,11-dioxo-3,6,13,16-tetrakis(phenylmethyl)-, 1,18-bis(5-thiazolylmethyl) ester, (3S,4S,6S,10S,13S,15S,16S)-
C52H61N7O8S2
976.2 g/mol
Research Reagent

Ritonavir EP Impurity S

CAS2084828-53-3
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

Ritonavir EP Impurity S is a chemical compound used as a pharmaceutical impurity reference standard. It is primarily employed in quality control and analytical testing during the manufacturing of the antiretroviral drug ritonavir.

pharmaceutical impurity reference standardanalytical testing in quality control

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Ritonavir EP Impurity S?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

4-[4-(1-adamantyl)phenyl]-2-phenylaniline

CAS2086312-08-3

research compound

ReferenceSame Category

5-(Methylthio)thiophene-2-carboxylic acid

CAS20873-58-9

research compound

ReferenceSame Category

4-(4-Cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxamide

CAS2087452-81-9

research compound

ReferenceSame Category

(4-Bromonaphthalen-1-yl)diphenylphosphine Oxide

CAS2087511-26-8

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-1-[[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-(1,3-thiazol-5-ylmethoxycarbonylamino)hexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamoylamino]-1,6-diphenylhexan-2-yl]carbamate

InChIKey

UFFLDXFQXNYZLF-BHRSBNONSA-N

SMILES

CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C[C@@H]([C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)O)NC(=O)N[C@@H](CC4=CC=CC=C4)C[C@@H]([C@H](CC5=CC=CC=C5)NC(=O)OCC6=CN=CS6)O

Synonyms (8)
  • Ritonavir EP Impurity S
  • RITONAVIR IMPURITY S

Sourcing Ritonavir EP Impurity S?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→